Sangamo Therapeutics Inc (SGMO) may enjoy gains as insiders got busy in the recent days
As this happened, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an
As this happened, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an
Taking this into account, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a
Meanwhile, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an Outperform in
While this happened, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an
While this happened, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an
Following these proceedings, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an
As this happened, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.